Acute Effect of Lemborexant on CSF Amyloid-Beta and Tau

Summary

This study will look at the effects of lemborexant on Alzheimer's disease biomarkers found in the cerebrospinal fluid (CSF) and blood in individuals who are poor sleepers

Timeline

Start

2023-03-01

Primary completion

2023-09-27

Completion

2023-10-04

Outcome

Outcome not reported

Stopped (Enrollment): “Study was terminated due to enrollment difficulties and the inability to obtain necessary study supplies. Five participants signed consent; however, no one was randomized. The study was officially terminated with the funding source on 10/04/2023.”

Drugs

Indications